Studies strongly suggest that loss of PGR or P4 signaling pathways [43] and activation of the PI3K/AKT/mTOR pathway [44,45] lead to P4 resistance in various uterine diseases, including CAH and EEC. Here, MTOR is linked to congenital adrenal hyperplasia.